This single, longer-acting R-enantiomer of the racemic modafinil has been approved as a wakefulness-promoting drug.
Peter Millin, PharmD Candidate
Advertisement
Articles by Peter Millin, PharmD Candidate
Advertisement
Latest Updated Articles
- Rx Product News: Profile: A Closer Look at New FDA Actions: Nuvigil
Published: June 1st 2008 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
From Stigma to Breakthrough: Psychedelic Medicine
2
CHEST 2025: Brensocatib Shows Potential to Slow Structural Lung Changes in Bronchiectasis
3
Pharmacists Can Drive Equitable Diagnostics Access, Improve Antimicrobial Resistance Stewardship
4
In the Fragmented Landscape of Long COVID Care, Pharmacists Are Essential
5
